期刊
ADVANCED HEALTHCARE MATERIALS
卷 12, 期 2, 页码 -出版社
WILEY
DOI: 10.1002/adhm.202201822
关键词
biomaterials; oxidized alginate; glucose-responsive insulin delivery; islet cell therapy
This study develops biodegradable, partially oxidized alginate carriers for glucose-responsive insulin delivery and islet cell transplantation therapy. The results demonstrate that these carriers can achieve glycemic control and reduce the volume of nondegradable material implanted.
Self-regulated insulin delivery that mimics native pancreas function has been a long-term goal for diabetes therapies. Two approaches towards this goal are glucose-responsive insulin delivery and islet cell transplantation therapy. Here, biodegradable, partially oxidized alginate carriers for glucose-responsive nanoparticles or islet cells are developed. Material composition and formulation are tuned in each of these contexts to enable glycemic control in diabetic mice. For injectable, glucose-responsive insulin delivery, 0.5 mm 2.5% oxidized alginate microgels facilitate repeat dosing and consistently provide 10 days of glycemic control. For islet cell transplantation, 1.5 mm capsules comprised of a blend of unoxidized and 2.5% oxidized alginate maintain cell viability and glycemic control over a period of more than 2 months while reducing the volume of nondegradable material implanted. These data show the potential of these biodegradable carriers for controlled drug and cell delivery for the treatment of diabetes with limited material accumulation in the event of multiple doses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据